← Back to Search

Behavioral Intervention

MAPP for Anxiety Disorders in Children (MAPP Trial)

N/A
Recruiting
Led By Golda S Ginsburg, PhD
Research Sponsored by UConn Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
6-17 years of age
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up youth will be assessed at 2 months (post intervention) and 6 months after eligibility is established.
Awards & highlights

MAPP Trial Summary

This trial aims to help pediatric primary care providers help kids who are struggling with anxiety.

Who is the study for?
This trial is for children aged 6-17 who show signs of anxiety, with scores indicating mild to moderate symptoms. It's designed to help pediatricians better support these kids, especially where mental health resources are scarce.Check my eligibility
What is being tested?
The MAPP clinical trial is testing a brief intervention called the Anxiety Action Plan (AxAP), aimed at reducing anxiety in children. Pediatric care providers will be trained and compared using AxAP versus Enhanced Usual Care involving educational materials.See study design
What are the potential side effects?
Since this study involves non-medical interventions like training and educational materials, traditional physical side effects are not expected; however, there may be emotional or psychological responses unique to each child.

MAPP Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 6 and 17 years old.

MAPP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~youth will be assessed at 2 months (post intervention) and 6 months after eligibility is established.
This trial's timeline: 3 weeks for screening, Varies for treatment, and youth will be assessed at 2 months (post intervention) and 6 months after eligibility is established. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Clinical Global Impression Improvement scale
Primary Care Provider

MAPP Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Managing Anxiety in Pediatric Primary Care (MAPP)Experimental Treatment1 Intervention
Participants receive approximately 4 sessions of a primary care provider-delivered intervention for reducing youth anxiety symptoms based on exposure therapy.
Group II: Enhanced Usual Care (EUC)Placebo Group1 Intervention
Participants receive a list of resources on how to reduce anxiety (e.g., videos, books, etc.).

Find a Location

Who is running the clinical trial?

UConn HealthLead Sponsor
211 Previous Clinical Trials
60,561 Total Patients Enrolled
2 Trials studying Anxiety
134 Patients Enrolled for Anxiety
National Institute of Mental Health (NIMH)NIH
2,786 Previous Clinical Trials
2,689,639 Total Patients Enrolled
82 Trials studying Anxiety
39,040 Patients Enrolled for Anxiety
National Institutes of Health (NIH)NIH
2,701 Previous Clinical Trials
7,506,790 Total Patients Enrolled
13 Trials studying Anxiety
19,151 Patients Enrolled for Anxiety

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are elderly applicants being considered for this experiment?

"Prospective participants aged 6 to 17 are eligible for recruitment into this medical research; any younger or older individuals cannot take part."

Answered by AI

Who meets the criteria for participation in this medical experiment?

"To qualify for this study, applicants should be diagnosed with an anxiety disorder and between the ages of 6 to 17. Approximately 60 participants will be accepted into the trial."

Answered by AI

How many participants have been recruited to take part in this research?

"Affirmative. Clinicaltrials.gov displays that this medical study, which was first advertised on November 1st 2023, is accepting new participants. 60 individuals must be recruited from a single clinical site."

Answered by AI

Are any current openings available for participants in this experiment?

"That is accurate. According to the listing on clinicaltrials.gov, this medical research experiment is currently recruiting participants and was first unveiled in November 1st 2023. 60 individuals are needed from a single scientific site for the project."

Answered by AI

Who else is applying?

What site did they apply to?
UConn Health
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
Managing Anxiety in Pediatric Primary Care (MAPP)
Golda S. Ginsburg 2023. "Managing Anxiety in Pediatric Primary Care (MAPP)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06104904.
All > Anxiety Disorder
~40 spots leftby Jan 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top